Finance

Citigroup is considering working with pot companies as banks figure out ways to chase a $75 billion market

FILE - This Feb. 17, 2016 file photo shows marijuana plants at a home in Honolulu. Hawaii is among the bluest of states, but when it comes to legalizing marijuana, it is out of step with liberal stalwarts such as California and Vermont. A bill that would legalize marijuana in the islands faces significant obstacles from leaders worried about contradicting federal law and jeopardizing Hawaii’s existing medical marijuana program. It faces a Friday, March 1, 2019, deadline to pass committee. (AP Photo/Marina Riker, File)
Cannabis is still illegal in the US at the federal level, making it tricky for US banks to service companies from the industry. Associated Press
Read in app

Citigroup has held talks in recent weeks about how closely it should work with cannabis companies or clients in other industries who want a loan to invest in the marijuana market, according to people with knowledge of the talks. 

One particular meeting earlier this year involved Bradford Hu, the bank's chief risk officer, Ed Skyler, global head of public affairs, and Jamie Forese, the firm's president and head of the unit that houses the investment bank, according to one of the people. All three sit on the firm's operating committee. 

The executives had seen competitors participating around the edges of the industry, such as by financing purchases of stakes in cannabis companies, and wanted to be proactive in considering how they'd respond if a client came to them with a similar request, one of the people said. 

See also: Check out our exclusive list of the top 12 venture capital firms making deals in the booming marijuana industry

Another meeting in February involving more junior staff focused on reputational issues that might arise from working with an industry that's hung up in a legal gray area, according to a second person. Citigroup conducted a similar review over its involvement in the Dakota Access Pipeline, an oil pipeline routed through Native American lands that sparked months of protest.  

The senior executives ultimately decided against setting a firmwide policy. Citigroup will continue to take action on a case by case basis and in full consideration of federal laws, one of the people said. A spokeswoman declined to comment. 

As more states legalize cannabis, more and more banks are looking for reasons to work with an industry that's projected to reach $75 billion in the US alone by 2030. More than 430 US banks count cannabis companies as clients in one way or another, according to a December report from the Treasury Department. Another 113 credit unions work with the industry, according to the report.

Read more: Big asset managers like BlackRock are sitting on the sidelines of the $75 billion US marijuana industry because of one big pain point

And some larger banks are beginning to find ways to make money from the industry's growth. JPMorgan provided financing to Altria Group for its purchase of a minority stake in Canadian pot producer Cronos Group in December. Lazard Ltd.'s Canadian subsidiary represented Cronos.  

Bank of America provided financing to Constellation Brands for its $4 billion investment into another Canadian pot cultivator Canopy Growth. Goldman Sachs advised Constellation on the purchase, while Greenhill & Co's Canadian subsidiary advised Canopy Growth. 

Citigroup and other banks are also grappling with whether or not they should act as prime brokers to hedge funds that specialize or invest in US cannabis companies, according to a third person with knowledge of the firm's deliberations. 

Sign up here for our weekly newsletter Wall Street Insider, a behind-the-scenes look at the stories dominating banking, business, and big deals.

Read next

Jeremy is the founder and editor-in-chief of Cultivated Media, a newsletter bringing readers inside the emerging cannabis industry. Beyond his reporting, Jeremy is studying for his MBA at Columbia Business School and holds a certificate in cannabis pharmacology from the University of Vermont where he studied as a cannabis media fellow. Jeremy was formerly a senior reporter at Insider where he focused on the cannabis industryJeremy has covered the bumpy rollout of Canada's cannabis legalization, the boom in cannabis companies going public (and the resulting fallout), multibillion-dollar mergers between cannabis companies and corporations from other industries, the ongoing health effects from vaporizers, the mislabeling of CBD products, and how the world's largest financial, legal, and political institutions are reacting to and planning for legalization. He has also gotten scoops and broken news on layoffs affecting cannabis companies, startups raising money, banks and law firms building specialized cannabis practices, tracked which companies and individuals are profiting from cannabis, and profiled some of the top executives, investors, and leaders in the industry.He is a sought-after expert on cannabis business and policy, frequently speaking to the media and at industry conferences.
A headshot
Dakin Campbell
Dakin Campbell was a chief correspondent on Business Insider's enterprise team until May 2026. He has covered the environmental and societal impacts of AI, the underbelly of reality TV, corporate governance battles at Goldman Sachsromantic entanglements in a Texas bankruptcy court, and the murky world of private equity fees, among others. He has won numerous journalism awards, including a Barlett & Steele and a Polk.Before joining BI in 2018, Dakin spent a decade at Bloomberg News. He’s a graduate of Cornell University and Columbia University, and once held the CFA charter — until he stopped paying dues.He can be reached on Signal at dakin.11, at his personal website, and on Twitter, Bluesky, and LinkedIn.